Company / Interest Expense
Inmune Bio, Inc. Interest Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$789.0K
FY2025
5-year range
$789.0K / $2.3M
FY2022-FY2025
Trend
-65.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $789,000 over the past 2 years.
Based on SEC 10-K filings.
$789,000 in FY2025 with a 3-year CAGR of -7.1%.
Improved from $2M to $789,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -7.1%, indicating a declining trend.
- In FY2025, interest expense decreased 65.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $789.0K | -65.4% |
| FY2024 | $2.3M | +13.1% |
| FY2023 | $2.0M | +104.5% |
| FY2022 | $985.0K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026